Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05936931 · ClinicalTrials.gov registry record · NA

Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening

A NA study, sponsored by Virginia Commonwealth University.

Not yet
Registry status
NA
Development phase
30
Enrollment target

NCT05936931: Clinical Trial NA study, sponsored by Virginia Commonwealth University.

NCT05936931 is a NA study that has not yet begun recruiting, run by Virginia Commonwealth University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05936931, a NA study, has not yet begun recruiting, sponsored by Virginia Commonwealth University.

NOT YET RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

This study will garner preliminary data to develop a young adult-mediated intervention whereby a younger family member encourages their older family member to get colorectal cancer (CRC) screening. In Aim 1, survey data from n=150 younger (25-44 years old) and n=150 older (45-75 years old) adults living in rural communities will be collected. In Aim 2, intervention components will be evaluated using n=9 focus groups. The novel intervention will be assessed via a pilot trial (n=15 adult child/parent dyads) in Aim 3.

Primary Outcome

A composite index score on four awareness items and 14 knowledge items adopted from prior research

Interventions

  • BEHAVIORAL Changes in CRC screening awareness and intentions

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-07-31
Est. Completion 2027-12-31
Phase NA
Virginia Commonwealth University

558 total trials

What is known before NCT05936931 opens enrollment

NCT05936931 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Changes in CRC screening awareness and intentions is the first listed.

NCT05936931 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05936931 about?

NCT05936931 is a clinical study titled "Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening". This study will garner preliminary data to develop a young adult-mediated intervention whereby a younger family member encourages their older family member to get colorectal cancer (CRC) screening. In Aim 1, survey data from n=150 younger (25-44 years old) and n=150 older (45-75 years old) adults li...

What is the current status of trial NCT05936931?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-07-31. Estimated completion is 2027-12-31.

What interventions are being tested in trial NCT05936931?

The interventions under investigation include: Changes in CRC screening awareness and intentions (BEHAVIORAL).

Who is sponsoring clinical trial NCT05936931?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05936931's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05936931, the US trial registry maintained by the National Library of Medicine. NCT05936931 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.